These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16773239)

  • 1. Recombinant human alpha-1 proteinase inhibitor: towards therapeutic use.
    Karnaukhova E; Ophir Y; Golding B
    Amino Acids; 2006 Jun; 30(4):317-32. PubMed ID: 16773239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Practical applications of recombinant alpha-1-antitrypsin in medicine].
    Kabziński J; Kedziora J; Majsterek I
    Pol Merkur Lekarski; 2010 Dec; 29(174):345-50. PubMed ID: 21298982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha1-Antitrypsin deficiency: best clinical practice.
    Kalsheker NA
    J Clin Pathol; 2009 Oct; 62(10):865-9. PubMed ID: 19783716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the rapid plasma elimination of recombinant alpha 1-proteinase inhibitor: synthesis of polyethylene glycol conjugates with improved therapeutic potential.
    Mast AE; Salvesen G; Schnebli HP; Pizzo SV
    J Lab Clin Med; 1990 Jul; 116(1):58-65. PubMed ID: 2376698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha 1-antitrypsin augmentation therapy.
    Sandhaus RA
    Agents Actions Suppl; 1993; 42():97-102. PubMed ID: 8356934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of an ELISA for quantification of human alpha-1-proteinase inhibitor in complex biological mixtures.
    Karnaukhova E; Golding B; Ophir Y
    Biologicals; 2007 Oct; 35(4):285-95. PubMed ID: 17257853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of elastase inhibitors in emphysema treatment.
    Eriksson S
    Eur Respir J; 1991 Oct; 4(9):1041-3. PubMed ID: 1684550
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical features and molecular characteristics of alpha 1-antitrypsin deficiency.
    Blank CA; Brantly M
    Ann Allergy; 1994 Feb; 72(2):105-20; quiz 120-2. PubMed ID: 8109800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation therapy of alpha 1-antitrypsin deficiency.
    Hubbard RC; Crystal RG
    Eur Respir J Suppl; 1990 Mar; 9():44s-52s. PubMed ID: 2340051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, purification and characterization of recombinant Z alpha(1)-antitrypsin--the most common cause of alpha(1)-antitrypsin deficiency.
    Levina V; Dai W; Knaupp AS; Kaiserman D; Pearce MC; Cabrita LD; Bird PI; Bottomley SP
    Protein Expr Purif; 2009 Dec; 68(2):226-32. PubMed ID: 19555763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 1-PI for emphysema due to alpha 1-antitrypsin deficiency.
    Horowitz ID; Schulman ES
    Am Fam Physician; 1989 Sep; 40(3):223-8. PubMed ID: 2672752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha 1-proteinase inhibitor for alpha 1-antitrypsin deficiency.
    Med Lett Drugs Ther; 1988 Mar; 30(761):29-30. PubMed ID: 3257810
    [No Abstract]   [Full Text] [Related]  

  • 13. alpha-1-Antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse.
    Churg A; Wang RD; Xie C; Wright JL
    Am J Respir Crit Care Med; 2003 Jul; 168(2):199-207. PubMed ID: 12689849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha 1-antitrypsin. Hope on the horizon for emphysema sufferers?
    Schwaiblmair M; Vogelmeier C
    Drugs Aging; 1998 Jun; 12(6):429-40. PubMed ID: 9638392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
    Abboud RT; Vimalanathan S
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency.
    Louie SG; Sclar DA; Gill MA
    Ann Pharmacother; 2005 Nov; 39(11):1861-9. PubMed ID: 16219903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technology evaluation: transgenic alpha-1-antitrypsin (AAT), PPL therapeutics.
    Tebbutt SJ
    Curr Opin Mol Ther; 2000 Apr; 2(2):199-204. PubMed ID: 11249642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioengineering: alpha 1-proteinase inhibitor site-specific mutagenesis. The prospect for improving the inhibitor.
    Luisetti M; Travis J
    Chest; 1996 Dec; 110(6 Suppl):278S-283S. PubMed ID: 8989165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation therapy for emphysema due to alpha-1-antitrypsin deficiency.
    Tirado-Conde G; Lara B; Miravitlles M
    Ther Adv Respir Dis; 2008 Feb; 2(1):13-21. PubMed ID: 19124355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non enzymatic glycosylation of alpha-1-proteinase inhibitor of human plasma.
    Phadke M; Billimoria FR; Ninjoor V
    J Postgrad Med; 1998; 44(2):29-34. PubMed ID: 10703566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.